128 related articles for article (PubMed ID: 2832630)
21. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen.
Lundberg JM; Rudehill A; Sollevi A
Eur J Pharmacol; 1989 Apr; 163(1):103-13. PubMed ID: 2744085
[TBL] [Abstract][Full Text] [Related]
23. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
Han C; Abel PW
J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
Martin SE; Kuvin JT; Offenbacher S; Odle BM; Patterson RE
Am J Physiol; 1992 Oct; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock.
Hauser GJ; Myers AK; Dayao EK; Zukowska-Grojec Z
Am J Physiol; 1993 Oct; 265(4 Pt 2):H1416-23. PubMed ID: 7902007
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
Oellerich WF; Malik KU
J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
[TBL] [Abstract][Full Text] [Related]
27. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
28. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
[TBL] [Abstract][Full Text] [Related]
29. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
Schwieler JH; Hjemdahl P
J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
[TBL] [Abstract][Full Text] [Related]
30. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
Lundberg JM; Rudehill A; Sollevi A; Hamberger B
Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
[TBL] [Abstract][Full Text] [Related]
31. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone.
Franco-Cereceda A; Lundberg JM; Dahlöf C
Acta Physiol Scand; 1985 Jul; 124(3):361-9. PubMed ID: 3840319
[TBL] [Abstract][Full Text] [Related]
32. The effects of neuropeptide Y on myocardial contractility and coronary blood flow.
Awad SJ; Einstein R; Potter EK; Richardson DP
Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493
[TBL] [Abstract][Full Text] [Related]
33. Endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation.
Jones CJ; DeFily DV; Patterson JL; Chilian WM
Circulation; 1993 Apr; 87(4):1264-74. PubMed ID: 8384938
[TBL] [Abstract][Full Text] [Related]
34. Endothelin- and neuropeptide Y-induced vasoconstriction of human epicardial coronary arteries in vitro.
Franco-Cereceda A
Br J Pharmacol; 1989 Jul; 97(3):968-72. PubMed ID: 2667681
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog.
Modin A; Pernow J; Lundberg JM
Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766
[TBL] [Abstract][Full Text] [Related]
36. Postsynaptic adrenoceptor-mediated vasoconstriction in coronary and femoral vascular beds.
Chen DG; Dai XZ; Bache RJ
Am J Physiol; 1988 May; 254(5 Pt 2):H984-92. PubMed ID: 2896466
[TBL] [Abstract][Full Text] [Related]
37. Effects of neuropeptide Y on regulation of blood flow rate in canine myocardium.
Svendsen JH; Sheikh SP; Jørgensen J; Mikkelsen JD; Paaske WP; Sejrsen P; Haunsø S
Am J Physiol; 1990 Dec; 259(6 Pt 2):H1709-17. PubMed ID: 2260698
[TBL] [Abstract][Full Text] [Related]
38. Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus.
Setty S; Sun W; Martinez R; Downey HF; Tune JD
J Appl Physiol (1985); 2004 Jul; 97(1):431-8. PubMed ID: 14978008
[TBL] [Abstract][Full Text] [Related]
39. Dissociation of potentiation of Leu31 Pro34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery.
Yang XP; Chiba S
Jpn J Pharmacol; 2000 Jul; 83(3):197-205. PubMed ID: 10952068
[TBL] [Abstract][Full Text] [Related]
40. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
Yang XP; Chiba S
Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
